Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- BUSINESS NEWS IN BRIEF
September 25, 2006
- Sekisui Chemical to Acquire Daiichi Pure Chemicals
September 25, 2006
- Sawai to Reorganize Its Hansha by Region
September 25, 2006
- Daiichi Sankyo to Transfer All Shares of DRL to Fuji Film
September 25, 2006
- TOPICS Janssen-Cilag, Ortho Biotech Receive 2006 Prix Galien for Velcade
September 25, 2006
- MEDICAL DEVICE NEWS IN BRIEF
September 25, 2006
- Daiko to Focus on R&D Due to Difficulty in Making All Strengths Available
September 25, 2006
- Direct Price Bargaining between Makers and Med. Institutions
September 18, 2006
- MEDICAL DEVICE NEWS IN BRIEF
September 18, 2006
- Industry, JPA Oppose Korosho's Discussion Proposal on NHI Pricing and Revision Frequency
September 18, 2006
- NEW PRODUCTS
September 18, 2006
- Key Points of Discussion on the NHI Pricing Criteria and the Frequency of NHI Price Revisions
September 18, 2006
- Towa Pharmaceutical Begins Business with Suzuken Nationwide
September 18, 2006
- Chuikyo Approves NHI Price Listing of 13 API/20 Products
September 18, 2006
- Errorneous Medical Bills Remain at High Levels
September 18, 2006
- Asahi Kasei Files for ART-123 in Japan, Licenses It to Artisan Pharma Overseas
September 18, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 18, 2006
- Korosho Calls For Tax Break for Unapproved Drugs, Bio-hazard Measures
September 18, 2006
- Eisai Acquires 4 Oncology Products from Ligand
September 18, 2006
- REGULATORY NEWS IN BRIEF
September 18, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…